Boulder BioLabs Opens to Offer Medical Device Packaging, Distribution Testing Service
-- On-site contract service provides reliability, fast turnaround time --
Part of the Boulder BioMed family, Boulder BioLabs will offer on-site contract distribution and packaging validation, with products transitioning seamlessly from sterilization to testing. Developers can thereby avoid the time and risk associated with off-site transfers to secondary labs. Services include:
- Environmental resting
- Drop testing
- Compression testing
- Vibration testing
- Impact testing
- Accelerated aging testing
- Real-time aging testing
The in-house service gives medical device companies greater control over their commercialization timelines by streamlining the sterilization, distribution and packaging validation process, according to
"In a competitive market, a faster path to market can reduce production costs, help companies gain first-mover advantage, and potentially increase appeal to investors," adds Kasic. "Medical device innovators can move faster without sacrificing quality – which means they can get their products to patients, faster and more efficiently."
Boulder BioLabs (www.boulderbiolabs.com)
Boulder BioLabs is part of the Boulder BioMed family, a group of expert contract consulting businesses providing all the services life sciences companies need to get their products to market. Boulder BioMed provides a single source for device developers, providing full product development under one roof: ideation, design, engineering, manufacturing, sterilization and packaging, and regulatory affairs and quality assurance.
Boulder BioMed is based in
Media contact: Aimee Bennett, [email protected], 303-843-9840
View original content:https://www.prnewswire.com/news-releases/boulder-biolabs-opens-to-offer-medical-device-packaging-distribution-testing-service-302529561.html
SOURCE Boulder BioLabs
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Global Times: China's innovation-driven growth can support more inclusive global development, says Arkebe Oqubay
- AsiaFIN Holdings Corp. Announces Q2 2026 Earnings Webcast
- red violet Announces Pricing of $100 Million Underwritten Public Offering of Common Stock
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share